Second-quarter biotech job picture - Nature Biotechnology

México Noticias Noticias

Second-quarter biotech job picture - Nature Biotechnology
México Últimas Noticias,México Titulares
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 66 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 63%

Second-quarter biotech job picture. A quarterly snapshot of job expansions, reductions and availability in the biotech and pharma sectors

Two new East Coast gene therapy manufacturing facilities opened for business this past quarter. On June 8, Astellas Pharma opened a 135,000-square-foot facility in Sanford, North Carolina. The facility, which was begun in late 2019 by Audentes Therapeutics before it was acquired by Astellas in a $3 billion deal, will provide clinical- and commercial-scale manufacturing capabilities for Astellas’s pipeline of adeno-associated virus gene therapies. The site is expected to create 200 new jobs.

Moderna has agreed to a deal with the UK government to build the country’s first research and manufacturing facility dedicated to the development of mRNA vaccines against COVID-19 variants and other respiratory illnesses. Construction of the mRNA Innovation and Technology Centre is expected to begin this year, with the first mRNA vaccines produced in the UK due in 2025. Moderna also said it will expand its clinical trials in the UK.

Also in the UK, Brentford-based GSK opened a new $110 million ‘smart’ manufacturing plant in Barnard Castle. The fully automated facility is expected to streamline the manufacturing process, decrease waste, and hasten the launch of new medicines. Germany’s Merck KGaA announced its largest investment in a single life-science manufacturing site, saying it will spend $470 million to build a new manufacturing facility and increase membrane manufacturing capacity in Cork, Ireland. The two sites in Ireland aim to create more than 370 permanent jobs by the end of 2027.

Finally, Sana Biotechnology, which raised $588 million in its IPO last year, has announced plans for a new manufacturing site in Bothell, Washington. The new 80,000-square-foot facility will support the company’s multiple cell and gene therapy candidates.Nature Biotechnology

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

NatureBiotech /  🏆 231. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Broncos linebacker Joe Schobert’s whirlwind week ended with 32 snaps against BuffaloBroncos linebacker Joe Schobert’s whirlwind week ended with 32 snaps against BuffaloFive days after signing with the Broncos, inside linebacker Joe Schobert played 32 snaps and had two tackles in Saturday’s preseason loss at Buffalo.
Leer más »

Geno Smith takes all first team snaps for Seahawks offense in Monday practiceGeno Smith takes all first team snaps for Seahawks offense in Monday practiceJust three weeks remain until the Seattle Seahawks host Russell Wilson and the rest of the Denver Broncos for the season opener of Monday Night Football in Week 1 of the 2022 season. In the five...
Leer más »

Biggest Movers: ATOM up 12% on Tuesday, as NEAR Snaps Losing Streak – Market Updates Bitcoin NewsBiggest Movers: ATOM up 12% on Tuesday, as NEAR Snaps Losing Streak – Market Updates Bitcoin NewsCosmos was a notable gainer on Tuesday, as prices of the token rose by as much as 12% in the day. Near protocol was almost 10% higher.
Leer más »



Render Time: 2025-03-04 22:39:33